Literature DB >> 21607034

Radionuclide imaging with human polyclonal immunoglobulin (Tc-HIG) and bone scan in patients with rheumatoid arthritis and serum-negative polyarthritis.

G Gerasimou, E Moralidis, E Papanastasiou, G Liaros, T Aggelopoulou, E Triantafyllidou, N Lytras, L Settas, A Gotzamani-Psarrakou.   

Abstract

BACKGROUND AND AIM: Rheumatoid arthritis (RA) is a chronic polyarthritic syndrome in which actively inflamed joints coexist with others being in remission. Compatible bone scan (BS) reveals joints with increased activity due to degenerative alterations, whilst scanning with human polyclonal immunoglobulin (HIG) is capable to show which of the joints present active inflammation of the synovial membrane. The aim of the study is to investigate the utility of molecular imaging with HIG in patients suffering from RA. PATIENTS AND METHODS: Forty patients (9 males plus 31 females), suffering from painful polyarthritic syndrome, with a mean age 45.3±7 years and a duration of disease 18.3±4.2 months were enrolled in the study. Twenty-six of the patients were serum positive to RA factor, considered as suffering from RA, whilst fourteen of them were RA factor negatives and they were considered as patients with serum-negative polyarthritis. All patients were submitted to x-rays and ultrasound examination (US) in joints of interest, plus whole body BS with (99m)Tc-MDP and finally scan with (99m)Tc-HIG.
RESULTS: A total of 1680 joints have been evaluated. In 6 of the patients-two with serum negative RA (252 joints), radionuclide imaging with HIG was within normal limits, despite the fact that in compatible bone scan degenerative alterations have been mentioned in 30 joints. In all these patients disease was evaluated as inactive ("arthrotic changes"). In the remaining 34 patients-12 with serum negative RA (1428 joints), increased accumulation of HIG, concerning serum positive patients, has been mentioned to 163 joints ("arthritic changes"), whilst in the same group, BS revealed degenerative changes to 265 joints. Concerning serum negative patients, the respective results were 64 versus 190 joints. Increased uptake of HIG has been found in 189/226 swollen and painful joints (overall sensitivity according to clinical criteria 83.3%) and in 38 joints without any clinical evidence of inflammation, with clinical active inflammation presented after follow-up to 35 of them, yielding thus specificity at the level of 92%. Matched findings between these two methods have been mentioned to 185 out of 227 joints with an abnormal scan with HIG. Abnormal x-rays and US findings have been mentioned in 67 of the joints.
CONCLUSIONS: According to the above mentioned, BS in RA reveals joints being actively inflamed or not, whilst radionuclide study with HIG is capable to distinguish actively inflamed joints, even in patients with serum negative RA, in a greater extent than anatomical imaging modalities.

Entities:  

Keywords:  bone scan; human polyclonal immunoglobulin (99m Tc-HIG); radionuclide imaging; rheumatoid arthritis

Year:  2011        PMID: 21607034      PMCID: PMC3093143     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  36 in total

1.  Comparison of Tc-99m MDP, Tc-99m HSA and Tc-99m HIG uptake in rheumatoid arthritis and its variants.

Authors:  M Sahin; I Bernay; T Basoglu; F Canturk
Journal:  Ann Nucl Med       Date:  1999-12       Impact factor: 2.668

2.  Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

Authors:  D M van der Heijde; M A van 't Hof; P L van Riel; L A Theunisse; E W Lubberts; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

3.  Biokinetics and estimation of dose from 99mTc-labelled polyclonal human immunoglobulin (HIG).

Authors:  A Saptogino; W Becker; F Wolf
Journal:  Nuklearmedizin       Date:  1991-02       Impact factor: 1.379

4.  Detection of inflammatory lesions with radiolabelled immunoglobulins.

Authors:  D Blok; M von Ogtrop; J W Arndt; J A Camps; R I Feitsma; W Goedemans; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1990

5.  F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis.

Authors:  Gerhard W Goerres; Adrian Forster; Daniel Uebelhart; Burkhardt Seifert; Valerie Treyer; Beat Michel; Gustav K von Schulthess; Achim H Kaim
Journal:  Clin Nucl Med       Date:  2006-07       Impact factor: 7.794

6.  Measurement of synovial inflammation in rheumatoid arthritis with technetium 99m labelled human polyclonal immunoglobulin G.

Authors:  P A van der Lubbe; J W Arndt; W Calame; T C Ferreira; E K Pauwels; F C Breedveld
Journal:  Eur J Nucl Med       Date:  1991

7.  Comparison of Tc-99m HIG and three-phase Tc-99m MDP bone scintigraphy for evaluating the efficacy of Yttrium-90 silicate radionuclide synovectomy.

Authors:  Esra Arzu Gencoglu; Gulseren Aras; Ozlem Kucuk; Gulay Atay; Ibrahim Tutak; Sebnem Ataman; Ayfer Soylu; Erkan Ibis
Journal:  Clin Nucl Med       Date:  2003-04       Impact factor: 7.794

8.  Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis.

Authors:  M A Kropholler; R Boellaard; E H Elzinga; C J van der Laken; K Maruyama; R W Kloet; A E Voskuyl; B A C Dijkmans; A A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-29       Impact factor: 9.236

9.  Detection and quantitative analysis of joint activity inflammation with 99Tcm-polyclonal human immunoglobulin G.

Authors:  F Pons; F Moyá; R Herranz; M Solá; J A Del Olmo; C Piera; J Muñoz-Gómez; J Setoain
Journal:  Nucl Med Commun       Date:  1993-03       Impact factor: 1.690

10.  Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.

Authors:  Catherine Beckers; Clio Ribbens; Béatrice André; Stefaan Marcelis; Olivier Kaye; Luc Mathy; Marie-Joëlle Kaiser; Roland Hustinx; Jacqueline Foidart; Michel G Malaise
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

View more
  2 in total

1.  Bone Scintigraphy in the Diagnosis of Rheumatoid Arthritis: Is There Additional Value of Bone Scintigraphy with Blood Pool Phase over Conventional Bone Scintigraphy?

Authors:  Ji Young Kim; Yun Young Choi; Chan Woo Kim; Yoon-Kyoung Sung; Dae-Hyun Yoo
Journal:  J Korean Med Sci       Date:  2016-02-22       Impact factor: 2.153

2.  99mTc-radiolabeled Levofloxacin and micelles as infection and inflammation imaging agents.

Authors:  Mine Silindir-Gunay; Asuman Yekta Ozer
Journal:  J Drug Deliv Sci Technol       Date:  2020-02-08       Impact factor: 3.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.